Intelligent Bio Solutions Inc. last reported quarterly results on Aug 19, 2026, for Q4 FY2026 (the quarter ended Jun 30, 2026): revenue of $1.1 million (+35.8% year over year) and diluted EPS of -$1.56. It usually reports 36–50 days after a quarter ends. Based on that pattern, the next release is estimated for around Nov 6, 2026.
Results for Q1 FY2027, the quarter ending around Sep 30, 2026. Expected on a Friday. Based on last year's release for the same quarter on Nov 7, 2025. This is an estimate, not a date the company has announced.
Release dates are when the company filed its earnings announcement with the SEC (Form 8-K, Item 2.02); select a date to open the filing. It usually reports 36–50 days after a quarter ends. Figures are USD in millions, except EPS. The colored percent is the change from the same quarter a year earlier. Until a quarter's 10-Q or 10-K figures reach the SEC's data, they come from the earnings press release, and are shown only when its year-ago numbers match the filed ones. A dash means the figure could not be confirmed yet.
| Released | Quarter | Revenue | Net income | Diluted EPS |
|---|---|---|---|---|
|
Aug 19, 2026
50 days after quarter end
|
Q4 FY2026
ended Jun 30, 2026
|
1
+35.8%
|
-4
-26.5%
|
-1.56
+64.6%
|
|
May 14, 2026
44 days after quarter end
|
Q3 FY2026
ended Mar 31, 2026
|
1
+45.5%
|
-3
-12.5%
|
-1.80
+59.2%
|
|
Feb 5, 2026
36 days after quarter end
|
Q2 FY2026
ended Dec 31, 2025
|
1
+47.6%
|
-3
-19.0%
|
-2.82
+43.1%
|
|
Nov 7, 2025
38 days after quarter end
|
Q1 FY2026
ended Sep 30, 2025
|
1
+27.5%
|
-3
-11.1%
|
-0.35
+50.0%
|
|
Aug 7, 2025
38 days after quarter end
|
Q4 FY2025
ended Jun 30, 2025
|
1
+15.9%
|
-3
-11.0%
|
-4.42
-383.0%
|
|
May 13, 2025
43 days after quarter end
|
Q3 FY2025
ended Mar 31, 2025
|
1
-11.5%
|
-3
+14.6%
|
-4.41
-208.4%
|
|
Feb 6, 2025
37 days after quarter end
|
Q2 FY2025
ended Dec 31, 2024
|
1
-20.5%
|
-2
-14.2%
|
-4.96
-139.6%
|
|
Oct 29, 2024
29 days after quarter end
|
Q1 FY2025
ended Sep 30, 2024
|
1
+9.6%
|
-3
-10.7%
|
-0.70
+94.4%
|
Company profile
- Industry
- Surgical & Medical Instruments & Apparatus (SIC 3841)
- Listed as
- INBS (Nasdaq)
- Fiscal year ends
- June 30
- Incorporated in
- DE
- Headquarters
- New York, NY
- SEC filer status
- Non-accelerated filer, Smaller reporting company
- SEC CIK
- 1725430
- Former names
- GBS Inc. (until Oct 18, 2022); Glucose Biosensor Systems (Greater China) Holdings, Inc. (until Sep 19, 2019)
Other Surgical & Medical Instruments & Apparatus companies
- Stryker Corp SYK
- 3M Co MMM
- Boston Scientific Corp BSX
- Becton Dickinson & Co BDX
- Medline Inc. MDLN
- Resmed Inc RMD
- Dexcom Inc DXCM
- Fresenius SE & Co. KGaA FSNUY
All 151 Surgical & Medical Instruments & Apparatus companies
Source: SEC EDGAR filings. This is company-reported data, not investment advice.